IMS INstitute for Healthcare Informatics

presented by
Sponsored Post

Join us June 17th as we explore how a unified identity strategy, spanning patients, providers, and emerging solutions like Verato Identity Network enables accurate attribution, strengthens interoperability, and ultimately drives VBC success.

Report: Targeted therapies account for nearly half of oncology drug sales

Even as global sales for oncology drugs topped $91 billion last year, a new report suggests a combination of factors is having an impact on cancer treatment. More targeted therapies treating smaller patient populations, reimbursement, rising drug costs and more effective screening and behavior change will impact treatment in the future, according to a report […]